Android app Apple app link

Apellis Pharmaceuticals, Inc. (APLS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$24.37

$0.04 (0.16%)
Last update: 04:00 PM EST
Day's range
$23.88
Day's range
$24.63

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
11/06/2024 H.C. Wainwright Douglas Tsao $57.00 $27.01   111.03%
09/23/2024 Robert W. Baird Colleen Kusy $92.00 $31.75   189.79%
09/20/2024 Stifel Nicolaus Annabel Samimy $84.00 $31.68   165.15%
09/20/2024 Mizuho Securities Graig Suvannavejh $39.00 $36.73   6.18%
09/16/2024 Mizuho Securities Graig Suvannavejh $42.00 $37.62   11.64%
08/09/2024 Robert W. Baird Colleen Kusy $96.00 $37.66   154.91%
08/08/2024 Jefferies Akash Tewari $82.00 $37.66   117.74%
08/02/2024 H.C. Wainwright Douglas Tsao $83.00 $36.00   130.56%
07/26/2024 Robert W. Baird Colleen Kusy $86.00 $38.88   121.19%
07/01/2024 Mizuho Securities Graig Suvannavejh $49.00 $38.36   27.74%
05/23/2024 Wells Fargo Derek Archila $48.00 $43.60   10.09%
02/04/2024 Jefferies Akash Tewari $80.00 $68.16   17.37%
01/02/2023 Wells Fargo Derek Archila $58.00 $51.71   12.16%
11/08/2021 BMO Capital Matthew Luchini $69.00 $37.34   84.79%
11/08/2021 Wedbush Laura Chico $28.00 $37.34   -25.01%
09/30/2021 Jefferies Chris Howerton $74.00 $33.59   120.3%
09/30/2021 Cantor Fitzgerald Alethia Young $74.00 $33.59   120.3%
09/09/2021 Credit Suisse Tiago Fauth $38.00 $34.93   8.79%
06/30/2021 Cowen & Co. Phil Nadeau $70.00 $67.80   3.24%

Apellis Pharmaceuticals, Inc. FAQ's

Apellis Pharmaceuticals, Inc. has been rated by research analysts at Scotiabank, H.C. Wainwright, Robert W. Baird, Stifel Nicolaus, Mizuho Securities, Jefferies in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.